Topic · page 15 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 561–600 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lupus Sci Med22 Oct 2025
Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment
Cohort study
Lupus Sci Med20 Oct 2025
Does social support reduce bodily pain among African American women with SLE? Findings from a randomised controlled trial
Secondary analysis
RMD Open20 Oct 2025
Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual
Cohort study
Lupus16 Oct 2025
National epidemiological analysis of lupus in Chile: A registry-based study from 2013 to 2024
Cohort study
Rheumatology (Oxford)16 Oct 2025
Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study
Cohort study
Ann Rheum Dis16 Oct 2025
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
Guideline or statement
N Engl J Med16 Oct 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
Randomized controlled trial
Rheumatology (Oxford)15 Oct 2025
Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study
Randomized controlled trial
Arthritis Res Ther14 Oct 2025
Multimodal brain structural and functional analysis in systemic lupus erythematosus patients without overt neuropsychiatric manifestations: associations with disease duration, organ damage, and neurocognitive function
Cross-sectional study
Rheumatology (Oxford)13 Oct 2025
Long-term renal outcomes, cardiovascular events and severe infections in patients with lupus nephritis: MassiLUP cohort 2001–2022
Cohort study
Lupus Sci Med10 Oct 2025
Significant glomerular IgM deposition predicts poorer kidney outcomes in lupus nephritis compared with other forms of immune complex deposits
Cohort study
Rheumatology (Oxford)10 Oct 2025
Tubulointerstitial inflammation driving interstitial fibrosis and tubular atrophy predicts poor renal outcome in refractory lupus nephritis
Cohort study
Lupus Sci Med9 Oct 2025
Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework
Research article
Lupus9 Oct 2025
Renal iron expression and urinary transferrin excretion in lupus nephritis: A case-control study
Case-control study
Lupus Sci Med7 Oct 2025
Impact of rural residence on clinical outcomes in SLE: a systematic review
Meta-analysis
Lupus Sci Med7 Oct 2025
Programme evaluation of Strategies to Embrace Living with Lupus Fearlessly (SELF): an evidence-based digital programme to build and improve lupus self-management skills
Research article
RMD Open7 Oct 2025
Unveiling the clinical and genetic impact of neuropsychiatric involvement in systemic lupus erythematosus
Cohort study
Lupus6 Oct 2025
Sleep quality in patients with systemic lupus erythematosus: The role of emotional health in Tunisia
Cross-sectional study
Lupus Sci Med6 Oct 2025
Dyspigmentation and scarring in cutaneous lupus erythematosus
Cross-sectional study
Lupus Sci Med6 Oct 2025
Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis
Cohort study
Lupus Sci Med6 Oct 2025
Predictors of patient-reported outcomes phenotypes in SLE during remission: a cluster analysis approach
Cross-sectional study
RMD Open5 Oct 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective
Guideline or statement
RMD Open5 Oct 2025
Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial
Secondary analysis
Lupus3 Oct 2025
Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus
Cross-sectional study
Lupus3 Oct 2025
Reproductive health knowledge and contraceptive use in never pregnant systemic lupus erythematosus patients: A cross-sectional survey
Cross-sectional study
Lupus Sci Med2 Oct 2025
Epidemiology of patients with moderate-to-severe SLE in Sweden
Cohort study
Lupus Sci Med30 Sep 2025
NLR outperforms PLR in SLE diagnosis and prognosis: an AI-enhanced meta-analysis of 12 850 patients with ethnicity-specific cut-offs
Meta-analysis
Lupus Sci Med30 Sep 2025
Perceptions of ageing among middle-aged and older adults with SLE: a single-centre cross-sectional study
Cross-sectional study
RMD Open30 Sep 2025
Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage
Diagnostic or prognostic study
Arthritis Res Ther29 Sep 2025
Low-dose rituximab in lupus enteritis: a comparative study on its efficacy in modulating mucosal immunity and reducing inflammation
Cohort study
Lupus29 Sep 2025
Longitudinal assessment of disease burden in juvenile systemic lupus erythematosus: A multicenter study of activity and damage scores
Cohort study
Lupus Sci Med29 Sep 2025
Characterisation of systemic lupus erythematosus associated with immune checkpoint inhibitors: a pharmacovigilance study using FAERS database
Cohort study
Lupus Sci Med29 Sep 2025
Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura
Cohort study
Lupus Sci Med29 Sep 2025
Risk of preterm delivery and early pregnancy hydroxychloroquine use from a Californian lupus cohort
Cohort study
Lupus26 Sep 2025
Analysis of the serum 25(OH)D3 level and its correlation with immunological indexes in patients with systemic lupus erythematosus
Cross-sectional study
RMD Open25 Sep 2025
Patients with systemic lupus erythematosus (SLE) have an increased bisphenol A methylation score linked to SLE risk genes and selected clinical subphenotypes
Case-control study
Lupus24 Sep 2025
Development and initial content validation of a new version of the damage index in thrombotic antiphospholipid syndrome (DIAPSV2)
Guideline or statement
Clin Exp Rheumatol23 Sep 2025
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus
Case-control study
RMD Open23 Sep 2025
Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus
Diagnostic or prognostic study
Rheumatology (Oxford)22 Sep 2025
Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 561–600 of 1,848, newest first